Vincrinak 1mg Injection
Marketer
Nakularch Meditech Pvt. Ltd.
Salt Composition
Vincristine (1mg)
Overview Vincrinak 1mg Injection
Oncaspar 1mg Injection, an antineoplastic agent, treats various cancers including breast, non-small cell lung, pancreatic, renal, hematological malignancies (such as multiple myeloma and lymphomas), and bone cancers. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, often taking weeks or months; discontinuation should only occur with your doctor's approval. Common side effects include alopecia, peripheral neuropathy (numbness and tingling in extremities), and constipation. The drug can reduce white blood cell counts, increasing infection risk, and may, in some instances, induce uric acid-related kidney problems. Regular blood tests monitoring blood cell counts, cardiac function, hepatic function, and uric acid levels are necessary. Inform your physician of all concurrent medications, as interactions are possible. This injection is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment. Avoid direct eye contact to prevent irritation.
Primary Ingredients of Vincrinak 1mg Injection
There is no text provided to rephrase.
Uses of Vincrinak 1mg Injection
Cancers affecting the breast, lungs (non-small cell), pancreas, kidneys, blood (including multiple myeloma), lymphatic system, and bones.
Major Benefits of Vincrinak 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vincrinak 1mg Injection:
- Hair loss
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Constipation
How to use Vincrinak 1mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Vincrinak 1mg Injection works:
Vincrinak 1mg Injection inhibits DNA replication within cancerous cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vincrinak 1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administration of Vincrinak 1mg Injection is contraindicated during gestation due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is recommended.
Breast feedingUNSAFE
Administration of Vincrinak 1mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Administration of Vincrinak 1mg Injection may impair driving ability due to potential adverse effects.
KidneyCAUTION
For individuals with impaired kidney function, administering Vincrinak 1mg Injection requires careful consideration. A modified dosage of Vincrinak 1mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should use Vincrinak 1mg Injection cautiously. Dosage modification of Vincrinak 1mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Vincrinak 1mg Injection :
NA
Facts to Know About Vincrinak 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Vinca-derived anticancer agents |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Vinca Alkaloid Antimicrotubule Agents |
3,018 People bought this recently